Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abdominal Aortic Aneurysm Stabilization with Truncal Cells
2022-501935-18-00Phase 2Authorised
- Sponsor
- Grupo Pedro Jaén
- Start
- Feb 2024
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of CSCC_ASC in abdominal aortic aneurysm (AAA), sponsored by Grupo Pedro Jaén. Primary endpoints: Proportion of procedure-related adverse events, Proportion of adverse events related to mesenchymal stem cell infusion and 1 more. Planned start Feb 2024; status: authorised.
02
Drugs
CSCC_ASC
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on 2022-501935-18-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-501935-18-00.